Xiaomeng Hu

1.1k total citations · 1 hit paper
36 papers, 825 citations indexed

About

Xiaomeng Hu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Xiaomeng Hu has authored 36 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Immunology and 5 papers in Oncology. Recurrent topics in Xiaomeng Hu's work include Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (5 papers) and RNA Interference and Gene Delivery (4 papers). Xiaomeng Hu is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (5 papers) and RNA Interference and Gene Delivery (4 papers). Xiaomeng Hu collaborates with scholars based in China, United States and Switzerland. Xiaomeng Hu's co-authors include Zhiping Zhang, Yuling Bao, Tingting Wu, Songwei Tan, Li Tang, Xiangting Zhuang, Yuanyuan Guo, Yongdan Zhao, Qingle Song and Yugang Guo and has published in prestigious journals such as Nature Communications, Nature Biotechnology and Advanced Functional Materials.

In The Last Decade

Xiaomeng Hu

30 papers receiving 817 citations

Hit Papers

IL-10-expressing CAR T cells resist dysfunction and media... 2024 2026 2025 2024 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaomeng Hu China 13 327 322 317 238 186 36 825
Feifei Yang China 16 282 0.9× 340 1.1× 239 0.8× 211 0.9× 215 1.2× 32 837
Michael Fichter Germany 13 252 0.8× 261 0.8× 185 0.6× 257 1.1× 148 0.8× 30 781
Ting Su China 11 324 1.0× 530 1.6× 270 0.9× 185 0.8× 109 0.6× 21 784
Marisa Aikins United States 10 282 0.9× 296 0.9× 253 0.8× 124 0.5× 119 0.6× 10 646
Yonger Xue United States 15 573 1.8× 250 0.8× 235 0.7× 137 0.6× 167 0.9× 25 954
Ragy Ragheb United States 7 286 0.9× 374 1.2× 391 1.2× 260 1.1× 234 1.3× 7 823
Jason Bugno United States 15 578 1.8× 248 0.8× 288 0.9× 198 0.8× 275 1.5× 19 1.1k
Yingyue Ding United States 5 287 0.9× 271 0.8× 309 1.0× 132 0.6× 126 0.7× 6 691
Hathaichanok Phuengkham United States 11 308 0.9× 503 1.6× 572 1.8× 301 1.3× 161 0.9× 17 955
Xiaoyue Shi China 6 275 0.8× 421 1.3× 363 1.1× 114 0.5× 113 0.6× 14 829

Countries citing papers authored by Xiaomeng Hu

Since Specialization
Citations

This map shows the geographic impact of Xiaomeng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomeng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomeng Hu more than expected).

Fields of papers citing papers by Xiaomeng Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaomeng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomeng Hu. The network helps show where Xiaomeng Hu may publish in the future.

Co-authorship network of co-authors of Xiaomeng Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomeng Hu. A scholar is included among the top collaborators of Xiaomeng Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomeng Hu. Xiaomeng Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuanhui, Jie Gao, Wei Gu, et al.. (2025). The EZH2/MCM Complex/hTERT axis facilitates hepatocellular carcinoma progression by inhibiting cellular senescence. Mechanisms of Ageing and Development. 224. 112040–112040.
2.
Hu, Xiaomeng, Kathy White, Annabelle M. Friera, et al.. (2025). Hypoimmune CD19 CAR T cells treat allogeneic mice with features of spontaneous systemic lupus erythematosus. iScience. 28(7). 112806–112806. 1 indexed citations
3.
5.
Wan, Bowen, Yu Chen, Xiaohui Qiu, et al.. (2024). Longitudinal correlates of learning burnout among Chinese adolescents during the COVID-19 pandemic: A cross-lagged panel network analysis. Journal of Affective Disorders. 369. 125–134. 1 indexed citations
6.
Zhao, Yang, Jiangqing Chen, Massimo Andreatta, et al.. (2024). IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases. Nature Biotechnology. 42(11). 1693–1704. 144 indexed citations breakdown →
7.
Hu, Xiaomeng, et al.. (2024). Delivery approaches of immunomodulatory nucleic acids for cancer therapy. Current Opinion in Biotechnology. 89. 103182–103182. 3 indexed citations
8.
Hu, Xiaomeng, Kathy White, Chenyan Wang, et al.. (2024). The HIP mouse and all of its organs are completely invisible to allogeneic immune cells. iScience. 28(1). 111492–111492. 3 indexed citations
9.
Chen, Lu, Ling Li, Zhengxue Qiao, et al.. (2024). Exploring factors influencing the quality of life in diabetes: a network analysis-based study. Frontiers in Psychiatry. 15. 1431772–1431772.
10.
Qiu, Xiaohui, Zhengxue Qiao, Jiawei Zhou, et al.. (2024). Nurse burnout: deep connections and solutions revealed by network analysis. BMC Nursing. 23(1). 531–531. 5 indexed citations
11.
Zhang, Yuzhe, Yuxi Liu, Yan Zhang, et al.. (2024). Quaternization of porphyrin conjugated organic polymer as an effective photocatalyst for fast degradation of 2,4-D and BPA. Separation and Purification Technology. 347. 127639–127639. 10 indexed citations
12.
Gu, Wei, Yuanhui Wang, Xiaomeng Hu, et al.. (2024). The RNA-binding protein CMSS1 promotes the progression of non-small cell lung cancer by regulating the telomerase protein subunit hTERT. Life Sciences. 361. 123321–123321. 1 indexed citations
13.
Zhang, Yuzhe, Xiaomeng Hu, Zhenhao Fan, et al.. (2024). Post-synthetic sulfonation of resorcinarene-based porous organic polymer for superfast adsorption of diverse organic pollutants. Polymer. 313. 127738–127738. 1 indexed citations
14.
Li, Zhimin, Yajing Liu, Salah Fatouh Abou‐Elwafa, et al.. (2023). ZmGI2 regulates flowering time through multiple flower development pathways in maize. Plant Science. 332. 111701–111701. 7 indexed citations
15.
Wang, Yuanhui, Guanzhen Wang, Wei Gu, et al.. (2023). Research progress of small-molecule drugs in targeting telomerase in human cancer and aging. Chemico-Biological Interactions. 382. 110631–110631. 9 indexed citations
16.
Cao, Yingying, Dandan Dou, Dongling Zhang, et al.. (2022). ZmDWF1 regulates leaf angle in maize. Plant Science. 325. 111459–111459. 9 indexed citations
17.
Gao, Min, Yuqing Xie, Kewen Lei, et al.. (2021). A Manganese Phosphate Nanocluster Activates the cGAS‐STING Pathway for Enhanced Cancer Immunotherapy. Advanced Therapeutics. 4(8). 56 indexed citations
18.
Wei, Lixia, et al.. (2020). Redox-Responsive Polycondensate Neoepitope for Enhanced Personalized Cancer Vaccine. ACS Central Science. 6(3). 404–412. 51 indexed citations
19.
Bao, Yuling, Mingxing Yin, Xiaomeng Hu, et al.. (2016). A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery. Journal of Controlled Release. 235. 182–194. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026